EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Cancer Diagnosis During Pregnancy and Livebirth Outcomes in the Adolescent and Young Adult Horizon Study

Caroline Cochrane iD, Chelsea Anderson, Sara Mitra, Laura Green, Christopher D Baggett, Jennifer E Mersereau, Darios Getahun, Marilyn L Kwan, Chun R Chao, Lawrence H Kushi, Hazel B Nichols

Journal of Women's Health · 2025

DOI: 10.1089/jwh.2024.0064 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Women's Health, 2025. Verfasst von Caroline Cochrane und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of OB/Gyn, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA. Hauptthemen laut MEDLINE: Pregnancy Outcome, Live Birth, Pregnancy Complications, Neoplastic, Premature Birth. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To describe patterns of cancer treatment and live birth outcomes that followed a cancer diagnosis during pregnancy. Study Design: The Adolescent and Young Adult (AYA) Horizon Study is an observational study evaluating outcomes in survivors of the five most common types of cancer in this age group (15-39 years old). Of the 23,629 individuals identified diagnosed with breast, lymphoma, thyroid, melanoma, or gynecological cancer in North Carolina (2000-2015) and California (2004-2016), we identified 555 live births to individuals who experienced cancer diagnosis during pregnancy. Births to individuals diagnosed with cancer during pregnancy were matched ∼1:5 on maternal age and year of delivery to live births to individuals without a cancer diagnosis (N = 2,667). Multivariable Poisson regression was used to compare birth outcomes between pregnancies affected by a cancer diagnosis and unaffected matched pregnancies.

Results

Cancer diagnosis during pregnancy was associated with an increased risk of preterm delivery (prevalence ratio [PR] 2.70; 95% confidence interval [CI] 2.24, 3.26); very preterm delivery (PR 1.74; 95% CI 1.12, 2.71); induction of labor (PR 1.48; 95% CI 1.27, 1.73); low birth weight (PR 1.97; 95% CI 1.55, 2.50); and cesarean delivery (PR 1.18; 95% CI 1.04, 1.34) but not associated with low Apgar score (PR 0.90; 95% CI 0.39, 2.06). In our sample, 41% of patients received chemotherapy, half of whom initiated chemotherapy during pregnancy, and 86% received surgery, 58% of whom had surgery during pregnancy. Of the 19% who received radiation, all received radiation treatment following pregnancy.

Conclusion

We identified an increased risk of birth outcomes, including preterm and very preterm delivery, induction of labor, low birth weight, and cesarean delivery, to those experiencing a cancer diagnosis during pregnancy. This analysis contributes to the available evidence for those experiencing a cancer diagnosis during pregnancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnancy OutcomeLive BirthPregnancy Complications, NeoplasticPremature BirthHumansFemalePregnancyAdolescentYoung AdultAdultNorth CarolinaCaliforniaInfant, NewbornNeoplasmsCancer SurvivorsCesarean Section

Stichwörter der Autor:innen

cancer treatment in pregnancychemotherapy in pregnancypregnancy outcomespregnancy-associated cancer

Autor:innen und Institutionen

  • Department of OB/Gyn, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA.
  • Gillings School of Global Public Health, Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Shady Grove Fertility, Raleigh, North Carolina, USA.
  • Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
  • Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA.

ORCID-Profile: Caroline Cochrane

Förderung

  • NCI NIH HHS

Zitieren

APA

Cochrane, C., Anderson, C., Mitra, S., Green, L., Baggett, C. D., Mersereau, J. E., Getahun, D., Kwan, M. L., Chao, C. R., Kushi, L. H., & Nichols, H. B. (2025). Cancer Diagnosis During Pregnancy and Livebirth Outcomes in the Adolescent and Young Adult Horizon Study. Journal of Women's Health. https://doi.org/10.1089/jwh.2024.0064

Vancouver

Cochrane C, Anderson C, Mitra S, Green L, Baggett CD, Mersereau JE, et al. Cancer Diagnosis During Pregnancy and Livebirth Outcomes in the Adolescent and Young Adult Horizon Study. Journal of Women's Health. 2025. doi:10.1089/jwh.2024.0064

BibTeX
@article{Cochrane2025,
  author = {Cochrane, Caroline and Anderson, Chelsea and Mitra, Sara and Green, Laura and Baggett, Christopher D and Mersereau, Jennifer E and Getahun, Darios and Kwan, Marilyn L and Chao, Chun R and Kushi, Lawrence H and Nichols, Hazel B},
  title = {Cancer Diagnosis During Pregnancy and Livebirth Outcomes in the Adolescent and Young Adult Horizon Study},
  journal = {Journal of Women's Health},
  year = {2025},
  doi = {10.1089/jwh.2024.0064}
}
Kostenlos starten →